Evaluation of Cardiovascular Risk Factors in Diabetic Patients in Two Regions with Differences in Race, Culture and Climate

Document Type : Original Article

Authors

1 Departmet of Endocrinologist, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

2 Departmet of Internal Medicine Kerman Medical University, Kerman, Iran.

3 Assistant Professor of Exercise Physiology, Shahid Bahonar University, kerman, Iran.

4 Musculoskeletal Rehabilitation, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Abstract

Background& Objective: The aim of this study is evaluation of cardiovascular risk factors in diabetic patients between two cities Kerman and Ahvaz with difference in culture, race and climate.
Subjects & Methods: In this crass-sectional study we enrolled 211 diabetic patients from Golestan diabetes care center of Ahvaz and 190 diabetic patients who were referred to Samen diabetes care center in Kerman. A questionnaire completed after direct interview examination and libratory assessment. The data were analyzed by SPSS 15 software. Standard chi-square test was used to compare the prevalence rates and the Means were compared by standard t test.
Results: Thetotal number of patients from Golestan center of Ahvaz was 211 (144 female (68.6%) and 67 male (31.4%)) with mean age of 55.52±10.32 years old and mean of duration of disease 6.72±6.39 years. Also thetotal number of patients from Samen center of Kerman was 190 (161 female (85.5%) and 29 male (14.5%)) with mean age of 54.37± 9.75 years old and mean of duration of disease 8.78 ±7.48 years.Overall, arterial hypertension, cigarette smoking and low HDL-C were more frequent between Ahvasien patients (P<0.0001, P=0.0004 and P<0.0001 respectively (.In contrast 20.4% of Kermanien patients were opium user and dyslipidemy as trouble in triglyceride were more frequent between them (P<0.0001 and P =0.027 respectively (. Renal insufficiency and uncontrolled diabetes were frequent in both two groups and there was no statistically significant different between them.
 Conclusion: Cardiovascular risk factors are frequent between the patients of both two cities. Differences in race; climate and social habits may be the related causes of higher prevalence of hypertension in Ahvaz and dyslipidemia in Kerman.

Keywords

References

1-Adler AI, Neil HA, Manley SE, Holman RR, Turner RC. Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47). Am Heart J 1999; 138(5Pt 1):S353-9.
2-International Diabetes Federation (IDF) Atlas. Available At: URL:  [http:// www. eatlas. idf.org /Complications/]. 2011.
3-International Diabetes Federation. Clinical guidline task for : a guide for clinical guidline development. Brussels: IDF; 2011.
4-Eccles, Mason J. How to develop cost-conscious guidelines? Health Technol Assess 2001; 5(16):1-69.
5-Barnett E, Casper ML, Halverson JA, Elmes GA, Braham VE, Majeed ZA, et al. Men and heart disease: an atlas of racial and ethnic disparities in mortality. Atlanta: Centers for Disease Control and Prevention; 2001.
6-Behavioral Risk Factor Surveillance System. Centers for Disease Control and Prevention. Available at: URL: http://apps.nccd.cdc.gov/brfss/. 2011.
7-Matthews KA, Sowers MF, Derby CA, Stein E, Miracle-McMahill H, Crawford SL, et al. Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN). Am Heart J 2005; 149(6):1066-73.
8-Klatsky AL, MD, Armstrong MA. Cardiovascular risk factors among asian americans living in northern California. Am J Public Health 1991; 81(11):1423-8.
9-Franz KB, Bailey SM. Geographical variations in heart deaths and diabetes: effect of climate and a possible relationship to magnesium. J Am Coll Nutr 2004; 23(5):521S–4.
10-Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med 1996;156(11):1143–8.
11-Rosolova H, Mayer O Jr, Reaven G. Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects. J Clin Endocrinol Metab 1997;82(11):3783–5.
12-Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med 1999; 159(18):2151–9.
13-Ford ES. Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int J Epidemiol 1999; 28(4):645-51.
14-Rasmussen HS, Aurup P, Hojberg S, Jensen EK, McNair P. Magnesium and acute myocardial infarction. Transient hypomagnesemia not induced by renal magnesium loss in patients with acute myocardial infarction. Arch Intern Med 1986; 146(5):872–4.
15-Martens WJ. Climate change, thermal stress and mortality changes. Soc Sci Med 1998; 46(3):331-44.
16-Arlyn G, Aaron L. Many people with diabetes do not know or heed dangers of hot weather. 2010.www.endo-society.org.
17-Dodgeon Mrh, Place SNrC. Romance the eastern frontier and the Persian wars: in documentary history. Hamilton. London: 2002.
18-Consummation opium on Iran. Atlas sur l’Iran. www.wikipedia.org.
19-Iranian ethnic groups. Copy right © 2001- 2011. Iranian chamber society
20-Fauci A, Braunwald O, Kasper D, Hauser S, Longo D, Jameson J, et al, eds. Harrison’s principles of internal medicine. 17th ed. New York: McGraw-Hill; 2008. P. 2290-1.
21-Lori N. Causes of Low HDL Cholesterol. 2009. Available At: URL: http://LIVESTRONG.COM.
22-Safaei H, Amini M. Albuminuria and its risk factors in newly diagnosed type 2 diabetes. Iran J Endocrinol Metab2007; 8(4):375-82. [In Persian]
23-Bonackdaran SH, Taghavi M. [Cardiovascular risk factors in type 2 diabetic patients in Mashhad city]. Iran J Endocrinol Metab 2010; 12(1):1-6. [In Persian]
24-Shahbazian HB, Shahbazian HA, Roshanpajuh F. The prevalence of diabetic nephropathy in patients with type 2 diabetes at Diabetes Clinic in Ahvaz. Jundishapur Sci Med J 2005; 4:317-22.
25-Bangstad HJ, Østerby R, Rudberg S, Hartmann A, Brabrand K, Hanssen KF. Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria. Diabetologia 2002; 45(2):253-61.
26-Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353(25):2643-53.
27-Kalaitzidis R, Bakris G. Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockers. Diabetes Obes Metab 2009; 11(8):757-69.
28-lawlor DA, Smith GD,  Mitchell R, Ebrahim S. Adult blood pressure and climate conditions in infancy: a test of the hypothesis that dehydration in infancy is associated with higher adult blood pressure. Am J Epidemiol (2006); 163(7):608-14.
29-Hansen AL, Bi P, Ryan P, Nitschke M, Pisaniello D,Tucker G. The effect of heat waves on hospital admissions for renal disease in a temperate city of Australia. Int J Epidemiol 2008; 37(6):1359-65.
30-Semenza JC, McCullough JE, Flanders WD, McGeehin MA, Lumpkin JR. Excess hospital admissions during the July 1995 heat wave in Chicago. Am J Prev Med 1999; 16(4):269–77.
31-Semenza JC. Acute renal failure during heat waves. Am J Prev Med 1999; 17(1):97.
32-Bagshaw SM, Laupland KB, Doig CJ, Mortis G, Fick GH, Mucenski M, et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a populationbased study. Crit Care 2005; 9(6):R700–9.
33-What dose warm weather do to blood pressure? 2011. Available at: URL: http://www.endo-society.org. 2010.
34-Liao SY, Tseng WC, Chen PY, Chen CC, Wu WM. Estimating the economic impact of climate change on cardiovascular diseases--evidence from Taiwan. Int J Environ Res Public Health 2010; 7:4250-66.
35-Braga AL, Zanobetti A, Schwartz J. The effect of weather on respiratory and cardiovascular deaths in 12 U.S. cities. Environ Health Perspect 2002;110(9):859-63.
36-Basu R, Samet JM. Relation between elevated ambient temperature and mortality: a review of the epidemiologic evidence. Epidemiol Rev 2002; 24(2):190-202.
37-Shirani S, Shakiba M, Soleymanzadeh M, Esfandbod M. Can opium abuse be a risk factor for carotid stenosis in patient who are candidates for coronary artery bypass grafting? Cardiol J 2010; 17(3):254-8.
38-Asgary S, Sarrafzadegan N, Naderi GA, Rozbehani R. Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and rout of administration matter? Lipids Health Dis 2008;7:42.
39-Sadr SS, Mahmoudinia SAR, Bakhtiari M. Friquency of opium use among diabetic patients and their attitude. Iran J Psychiatry Behav Sci 2009;3(2):33-8.
40-Fatemi SS, Hasanzadeh M, Arghami A, Sargolzaee MR. Lipid profile comparison between opium addicts and non-addicts. J Tehran Heart Center 2008;169-72.
41-Karam GA, Reisi M, Kaseb AA, Khaksari M, Mohammadi A, Mahmoodi M. Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus.. Addict Biol 2004; 9(1):53-8.
42-Lubree HG, Rege SS, Bhat DS, Raut KN, Panchnadikar A, Joglekar CV, et al. Body fat and cardiovascular risk factors in Indian men in three geographical locations. Food Nutr Bull 2002; 23(3 Suppl):146-9.
43-Al-Maskari F, El-Sadig M, Norman JN. The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates. Cardiovasc Diabetol  2007; 6:24.
44-Al-Amer RM, Khader Y, Malas S, Abu-Yaghi N, Al-Bdour  M, Ajlouni K. Prevalence and risk factors of diabetic retinopathy among Jordanian patients with type 2 diabetes.  Digit J Ophthalmol  2008; 14(2).
45-Ziaaddini H, Ziaadini MR. The household survey of drug abuse in Kerman, Iran. J Appl Sci 2005; 5(2):380-2.
46-Zargham M, Khalilian AR, Tajic Jalayeri H, Khadivi Sohrabi S. Study of frequency, situation and beliefs on opium consumtion in the elderly. Proceedings of the congress on Addiction, challenges, treatments. 18-20, Jan, 2002; Zanjan, Iran. [In Persian]
47-Ghazvininejad H. Incorrect beliefs on drugs. Proceedings of the congress on Addiction, challenges, treatments. 18-20, Jan, 2002; Zanjan, Iran. [In Persian]
Jundishapur Scientific Medical Journal
Volume 12, Issue 4 - Serial Number 85
July and August 2013
Pages 363-373

Files

History

  • Receive Date: 22 October 2012
  • Revise Date: 09 December 2012
  • Accept Date: 19 February 2013

Share

How to cite

Statistics